Lupus is a chronic autoimmune disease in which your immune system mistakenly attacks your own healthy tissues and organs. The most common form, systemic lupus erythematosus (SLE), can affect nearly every part of the body, from your skin and joints to your kidneys, heart, and brain. About 85% of people with lupus survive at least 10 years after diagnosis, and 75% survive 20 years or more, though the disease requires lifelong management.
How Lupus Works Inside the Body
Normally, your immune system produces antibodies to fight infections. In lupus, the immune system loses its ability to distinguish between foreign invaders and your own cells. It produces “autoantibodies” that target your own tissues instead. These autoantibodies bind to proteins released by your own cells, forming clumps called immune complexes that circulate through the bloodstream and settle into organs.
Once these immune complexes lodge in tissue, particularly in the kidneys, blood vessels, or the lining of the heart, they trigger an inflammatory chain reaction. Immune cells swarm to the area, release inflammatory signals, and cause damage to the surrounding tissue. This is why lupus can flare in so many different organs at once: the autoantibodies travel everywhere blood flows. The process is self-reinforcing. Damaged cells release more of the material that autoantibodies recognize, which creates more immune complexes, which causes more inflammation.
Common Symptoms
Lupus is famously unpredictable. Two people with the disease can have completely different experiences. That said, the most common symptoms include:
- Persistent fatigue that doesn’t improve with rest
- Joint pain, stiffness, and swelling, often in the hands, wrists, and knees
- A butterfly-shaped facial rash across the cheeks and bridge of the nose, which worsens with sun exposure
- Fever without an obvious infection
- Fingers and toes that turn white or blue in cold temperatures or during stress
- Chest pain and shortness of breath
- Headaches, confusion, and memory problems
The butterfly rash is one of the most recognizable signs, but many people with lupus never develop it. Symptoms tend to come and go in episodes called “flares,” separated by periods of remission where you feel relatively normal.
Who Gets Lupus
Lupus is six times more common in women than in men, and it most often appears during the childbearing years, between ages 15 and 44. Race plays a significant role in risk. Among U.S. adults studied through Medicaid data, African American women had the highest prevalence at roughly 286 per 100,000, followed by Asian women at about 255 per 100,000 and Hispanic women at around 163 per 100,000. These groups also tend to develop more severe disease with earlier onset.
Genetics load the gun, but environment pulls the trigger. Having a family member with lupus or another autoimmune disease raises your risk, though most people with those genetic predispositions never develop the condition.
What Triggers Flares
Ultraviolet light is one of the most well-documented triggers. Sun exposure doesn’t just cause a rash on exposed skin. True photosensitive reactions can appear up to three weeks after UV exposure and bring on fatigue and joint pain along with skin lesions. UV light can even provoke inflammation in internal organs. This is why sun protection is a core part of managing lupus, not just a cosmetic concern.
Other known triggers include emotional stress, infections, hormonal changes (such as during pregnancy), and certain medications. Cigarette smoking is particularly problematic because it interferes with the effectiveness of antimalarial drugs, which are a mainstay of lupus treatment.
Types of Lupus
Systemic lupus erythematosus is the most common and serious form, but it’s not the only one.
Cutaneous lupus affects only the skin. Discoid lupus, a subtype, causes thick, scaly patches that can scar. Subacute cutaneous lupus produces red, ring-shaped lesions that typically don’t scar but can be widespread.
Drug-induced lupus looks similar to SLE but is triggered by specific medications. The key difference is that it usually follows a milder course, rarely involving the kidneys or brain, and symptoms resolve after stopping the medication that caused them. That resolution after drug withdrawal is the most important clue that distinguishes it from true SLE.
Organ Complications
Roughly half of people with SLE experience blood abnormalities or neuropsychiatric symptoms at some point. But the kidneys are the organ most commonly threatened. When immune complexes deposit in the kidney’s filtering units, they cause lupus nephritis, a form of inflammation that can progress to kidney failure if untreated. Kidney involvement is one of the strongest predictors of long-term outcomes.
The heart is another major target. The pericardium, the sac surrounding the heart, is one of the most commonly affected structures, with postmortem studies finding evidence of involvement in about 62% of lupus patients. About one in 10 people with SLE develops a condition called Libman-Sacks endocarditis, where small growths form on the heart valves. The lungs can also be affected, with fluid accumulating around them or inflammation developing in the lung tissue itself.
How Lupus Is Diagnosed
There is no single test that confirms lupus. Diagnosis relies on a combination of symptoms, physical examination, and lab work. The first screening step is usually an antinuclear antibody (ANA) test. About 98% of people with systemic lupus test positive for ANA, making it the most sensitive blood test for the disease. However, a positive ANA alone doesn’t mean you have lupus. Many healthy people and people with other conditions also test positive.
When ANA is positive, doctors typically order additional antibody tests: anti-double-stranded DNA, anti-Smith, anti-Ro/SSA, anti-La/SSB, and anti-U1RNP. The presence of anti-double-stranded DNA or anti-Smith antibodies is particularly specific to lupus and carries significant weight in the diagnostic process.
The current classification system, established in 2019 by European and American rheumatology organizations, uses a point-based approach. A positive ANA at a specific threshold is the entry requirement. From there, findings across multiple categories (skin, joints, kidneys, blood counts, neurological symptoms, antibody results) are each assigned point values. Joint involvement scores 6 points, severe kidney inflammation scores 10, and the characteristic skin rash scores 6. A total of 10 or more points, with at least one clinical symptom, meets the classification threshold.
Treatment and Management
Lupus has no cure, but treatment can control inflammation, prevent flares, and protect organs from damage. Hydroxychloroquine, an antimalarial drug, is the cornerstone of lupus treatment. It’s recommended for virtually all lupus patients and is typically continued indefinitely, even when the disease is quiet. It reduces flares, protects against organ damage, and improves long-term survival.
During flares, corticosteroids are often used to quickly suppress inflammation. The goal is always to taper these down to the lowest effective dose, since long-term steroid use carries its own serious side effects, including bone thinning, weight gain, and increased infection risk. For more severe disease, especially when the kidneys or brain are involved, stronger immune-suppressing medications are added to bring the disease under control.
Beyond medication, daily management matters enormously. Rigorous sun protection (high-SPF sunscreen, protective clothing, avoiding peak UV hours) reduces both skin flares and systemic symptoms. Managing stress, getting adequate sleep, and staying physically active within your limits all contribute to fewer and less severe flares. Because lupus is a lifelong condition with periods of activity and remission, the treatment plan evolves over time, adjusted to match whatever the disease is doing at any given point.